Use of alkamides for masking an unpleasant flavor
View Patent ↗An individual alkamide and/or a mixture having two or more different alkamides, is disclosed for changing, masking or reducing the unpleasant flavor impression of an unpleasant-tasting substance or mixture of substances. The alkamide can be trans-pellitorine; cis-pellitorine; 2Z,4Z- or 2Z,4E-decadienoic acid-N-isobutylamide; 2E,4E-decadienoic acid-N-([2S]-2-methylbutyl)amide; 2E,4E-decadienoic acid-N-([2R]-2-methylbutylamide); 2E,4Z-decadienoic acid-N-(2-methylbutyl)amide; achilleamide; sarmentine; 2E- or 3E-decenoic acid-N-isobutylamide; 3E-nonenoic acid-N-isobutylamide; spilanthol; homospilanthol; 2E,6Z,8E-decatrienoic acid-N-([2R]-2-methylbutyl)amide; 2E- or 2Z-decen-4-oic acid-N-isobutylamide; α-sanshool; α-hydroxysanshool; γ-hydroxysanshool; γ-hydroxysanshool; γ-hydroxyisosanshool; γ-dehydrosanshool; γ-sanshool; bungeanool; isobungeanool; dihydrobungeanool; or tetrahydrobungeanool, or combinations thereof.
1. A method for masking or reducing the unpleasant flavor impression of an unpleasant-tasting substance or mixture of substances comprising mixing an astringent-tasting substance or mixture of astringent-tasting substances with 0.01 ppm to less than 10 ppm of one or more alkamides independently selected from the group consisting of:
wherein the total amount of the one or more alkamides is not sufficient to intensify salivation.
2. The method as claimed in claim 1 , wherein the one or more alkamides are formulated as a pharmaceutical preparation appropriate to be ingested orally or as a preparation used for nutrition, oral care, or consumption for pleasure.
3. The method as claimed in claim 2 , wherein the preparation used for nutrition is selected from the group consisting of soy-based products and fat-reduced (low-fat) yoghurts.
4. The method as claimed in claim 1 , wherein the one or more alkamides are mixed with one or more aroma substances which impart a milky/creamy flavor impression giving a sensation of fullness in the mouth and/or a sweet, caramel-like flavor impression.
5. The method as claimed in claim 4 , wherein the amount used of the aroma substance or substances synergistically intensifies the effect, changing, masking or reducing the unpleasant flavor impression.
6. The method of claim 1 , wherein the total amount of the one or more alkamides is less than 2 ppm and at least 0.01 ppm.
7. The method of claim 1 , wherein the total amount of the one or more alkamides is less than 1 ppm and at least 0.01 ppm.
8. A method for masking or reducing an astringent flavor impression comprising adding 0.01 ppm to less than 10 ppm of 2E,4E-decadienoic acid-N-isobutylamide (trans-pellitorine) to a preparation comprising an astringent-tasting substance, thereby masking or reducing the astringent flavor impression of the astringent-tasting substance in the preparation, provided that the amount of 2E,4E-decadienoic acid-N-isobutylamide (trans-pellitorine) is not sufficient to intensify salivation.
9. The method as claimed in claim 8 , wherein the preparation is formulated as a pharmaceutical preparation appropriate to be ingested orally or as a preparation used for nutrition, oral care, or consumption for pleasure.
10. The method as claimed in claim 9 , wherein the preparation used for nutrition is selected from the group consisting of soy-based products and fat-reduced (low-fat) yoghurts.
11. The method as claimed in claim 8 , wherein the 2E,4E-decadienoic acid-N-isobutylamide (trans-pellitorine) is mixed with one or more aroma substances which impart a milky/creamy flavor impression giving a sensation of fullness in the mouth and/or a sweet, caramel-like flavor impression.
12. The method as claimed in claim 11 , wherein the amount used of the aroma substance or substances synergistically intensifies the effect, changing, masking or reducing the unpleasant flavor impression.
13. The method of claim 8 , wherein the total amount of the 2E,4E-decadienoic acid-N-isobutylamide (trans-pellitorine) is less than 2 ppm and at least 0.01 ppm.
14. The method of claim 8 , wherein the total amount of the 2E,4E-decadienoic acid-N-isobutylamide (trans-pellitorine) is less than 1 ppm and at least 0.01 ppm.